Radiotherapy Side Effect Clinical Trial
Official title:
Comparison Between the Effect of Using Conventional and Digital Oral Positional Radiation Stent on Healthy Tissues, Salivary PH
The goal of this clinical trial is to compare between the Effect of Using Conventional and Digital Oral Positional Radiation Stent on Healthy tissues, salivary PH. The main question it aims to answer are: Does the difference in manufacturing method affect on Healthy tissues, salivary PH. Participants will use radiation positioning stent during radiotherapy sessions Two groups will be compared - Group A: OPRS was constructed according to the conventional technique. - Group B: OPRS was constructed digitally using CAD /CAM technology. to evaluate Dosimetric analysis to quantify the radiation dose in OARs, PH of saliva measurement and Mucositis assessment.
This study will be a clinically prospective study that will include 16 patients with head and neck cancer. This study will be carried out at the Clinical Prosthodontics Department & Clinical Oncology Department of Tanta University. Informed consent will be obtained from all patients with maintenance of their privacy prior to inclusion in the study according to the guidelines on human research adopted by the Research Ethics Committee, Faculty of Dentistry, Tanta University. Patient's evaluation: All patients will be subjected to the following protocol: Oral examination: Clinical dental evaluation, intraoral photography and mouth opening measurements Grouping: The patients will be divided randomly into 2 groups (each group consists of 8 patients) according to the technique that will be used for construction: First group: The OPRS will be constructed according to the conventional technique.27 Second group: The OPRS will be constructed digitally according to the following steps: Intraoral scanning: It will be done using an intraoral scanner to generate three 3D images: the first of the superior arch, the second of the inferior arch, and the third of the maximum habitual intercuspation. Images will be compiled into a 3D file system. Oral positioning radiation stent design: The compiled file will be exported into Exocad software, which is smart software for dental design on digital models, for stent design, and by using a virtual articulator. 3D printing: After optimizing the digital file, 3D printing will be performed. The oral positioning radiation stent will be printed using the 3D printer Resin Printing Material. For both groups: Insertion: making the necessary adjustment will be done. RT techniques and dose distributions: All patients will be referred to the RT department for IMRT planning. During the pre-irradiation simulation, the intraoral stents will be placed, and the patients will be immobilized by individual thermoplastic masks. A computed tomography scan will be conducted to determine the precise planning target volume (PTV); all patients will be scanned using the positional prosthesis once and without it. Dosimetric analysis: To quantify the radiation dose in the structures, the maxilla (area of the teeth), both parotid glands (ipsilateral and contralateral), the mandible, and the PTV will be defined and contoured in computed tomography pre-irradiation planning. The mean corresponding dose of each structure will be acquired using a dose-volume histogram. All patients will complete the radiotherapy sessions using the positional radiation prosthesis together with the extra oral immobilization masks. Mucositis assessment: The severity of mucositis will be assessed weekly from the beginning of RT to the end of the treatment (mean time, 7 weeks). It will be scored in accordance with the classification criteria of the National Cancer Institute. PH of saliva measurement: A saliva sample will be collected from each patient to measure salivary PH by digital PH meter 19 before the beginning of radiotherapy, and the measurement will be continued weekly until the end of the treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05543239 -
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain
|
N/A | |
Terminated |
NCT04535908 -
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.
|
N/A | |
Recruiting |
NCT04115267 -
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
|
||
Recruiting |
NCT05820633 -
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.
|
N/A | |
Completed |
NCT05880446 -
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
|
N/A | |
Recruiting |
NCT05724004 -
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
|
N/A | |
Recruiting |
NCT04612907 -
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
|
N/A | |
Recruiting |
NCT05762900 -
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
|
Phase 2 | |
Recruiting |
NCT03613506 -
The Role and Intervention of TGF-β in Abdominal Radiation Injury
|
Phase 2 | |
Not yet recruiting |
NCT05548504 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
Phase 2 | |
Recruiting |
NCT05224297 -
Patient Experience Data in Radiation Oncology
|
||
Recruiting |
NCT05776147 -
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
|
||
Completed |
NCT04842409 -
Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery
|
||
Recruiting |
NCT03742687 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
N/A | |
Not yet recruiting |
NCT05614700 -
Prostate Reirradiation Toxicity Outcomes Feasibility Study
|
N/A | |
Completed |
NCT04027543 -
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
|
||
Recruiting |
NCT05354596 -
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
|
N/A | |
Recruiting |
NCT03378856 -
Evaluation of Technological Innovation in Radiotherapy
|
||
Recruiting |
NCT03343236 -
Nutrition and Inflammation in Patients With Head and Neck Cancer
|